Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

NCT00542555 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

918

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: Placebo
DRUG: Naproxcinod 375 mg
DRUG: Naproxen
DRUG: Naproxcinod 750 mg

Sponsor

NicOx